Status:
COMPLETED
Acupuncture in Depression: From the Clinical Trial, Biomarkers to Molecular Biology
Lead Sponsor:
National Science and Technology Council, Taiwan
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Major depressive disorder (MDD) is a serious psychiatric illness with a high lifetime prevalence rate and causes major clinical, social and economic burden to patients and their family. Despite more t...
Detailed Description
In this study,the investigators will test the antidepressant effect of acupuncture versus sham intervention on major depression, in an eight-week, double-blind, randomized-controlled trial in 40 MDD p...
Eligibility Criteria
Inclusion
- Clinical diagnosis of major depressive disorder (MDD)
- Over 18 on the 21-item Hamilton Rating Scale for Depression
Exclusion
- Schizophrenia
- Ubstance dependence disorders
Key Trial Info
Start Date :
November 6 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03452384
Start Date
November 6 2014
End Date
October 31 2016
Last Update
March 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404